{"meshTags":["Antineoplastic Agents","Cetuximab","Colorectal Neoplasms","Disease-Free Survival","Humans","Mutation","Prospective Studies","Proto-Oncogene Proteins p21(ras)"],"meshMinor":["Antineoplastic Agents","Cetuximab","Colorectal Neoplasms","Disease-Free Survival","Humans","Mutation","Prospective Studies","Proto-Oncogene Proteins p21(ras)"],"genes":["KRAS G13D mutant metastatic colorectal cancer"],"publicationTypes":["Clinical Trial, Phase II","Letter"],"title":"Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer.","pubmedId":"26371285"}